Canada - English - Health Canada

merck canada inc - varicella virus live attenuated (oka/merck strain) - powder for solution - 1350unit - varicella virus live attenuated (oka/merck strain) 1350unit - vaccines

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ivax pharmaceuticals uk ltd - trimethoprim - oral tablet - 200mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ivax pharmaceuticals uk ltd - ferrous sulfate dried - oral tablet - 200mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ivax pharmaceuticals uk ltd - colchicine - oral tablet - 500microgram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ivax pharmaceuticals uk ltd - lamotrigine - oral tablet - 100mg

Singapore - English - HSA (Health Sciences Authority)

sanofi-aventis singapore pte. ltd. - hepatitis a virus (gbm strain), inactivated - suspension, sterile - 160 i.u./0.5 ml

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - hepatitis b vaccine, rdna 10 µg/ml - suspension for injection - 10 mcg/dose - active: hepatitis b vaccine, rdna 10 µg/ml excipient: aluminium as amorphous aluminum hydroxyphosphate sulphate borax formaldehyde potassium thiocyanate sodium chloride water for injection - indicated for immunisation against infection caused by all known subtypes of hepatitis b virus. should also prevent hepatitis d (caused by delta virus) since hepatitis d does not occur in the absence of hepatitis b infection.

Canada - English - Health Canada

merck canada inc - hepatitis b surface antigen (recombinant) - solution - 10mcg - hepatitis b surface antigen (recombinant) 10mcg - vaccines

Canada - English - Health Canada

merck canada inc - hepatitis b surface antigen (recombinant) - solution - 40mcg - hepatitis b surface antigen (recombinant) 40mcg - vaccines